[Clinical observation of TP regiment for treating refractory and terminal squamous cancer of the esophagus].
Yang
Yi-ming
YM
Department of Oncology, First Affiliated Hospital of Henan University, Kaifeng 475001, China. yangymch@sina.com
Zhang
Shui-lan
SL
Song
Hua-yong
HY
Li
Xu
X
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
D043823:Taxoids; D017239:Paclitaxel; D002945:Cisplatin